Get started
Work

Matching-Adjusted Indirect Comparison of Efficacy and Safety Outcomes for Lisocabtagene Maraleucel Versus Axicabtagene Ciloleucel and Tisagenlecleucel for the Treatment of Third-Line or Later Relapsed or Refractory Follicular Lymphoma

Year: 2024
Type: conference-paper
Abstract: Presented at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition; December 7—10, 2024; San Diego, CA, USA
Authors: Boardman, Alexander Paul, Reguera-Ortega, Juan Luis, Wang, Pearl, Ellis, Jenna, Bar, Merav, Kumar, Jinender, Farazi, Thalia, García-Sancho, Alejandro, Izutsu, Koji
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: green
OpenAlex ID: W7202013404
FWCI:
Cites:
Cited by:
Related to: 10